Tg Therapeutics reported $145K in Ordinary Share Capital for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Ardelyx ARDX:US USD 19K 4K
Bayer BAYN:GR EUR 2.52B 0
Biogen BIIB:US USD 100K 0
Corcept Therapeutics CORT:US USD 130K 2K
Curis CRIS:US USD 964K 46K
Infinity Pharmaceuticals INFI:US USD 89K 0
Intercept Pharmaceuticals ICPT:US USD 41K 11K
Karyopharm Therapeutics KPTI:US USD 8K 0
Novartis NOVN:VX USD 890M 0
Novavax NVAX:US USD 792K 4K
Ptc Therapeutics PTCT:US USD 71K 0
Roche Holding ROG:VX 107M 53M
Spectrum Pharmaceuticals SPPI:US USD 203K 18K
Tg Therapeutics TGTX:US USD 145K 0
Verastem VSTM:US USD 21K 2K
Vertex Pharmaceuticals VRTX:US USD 2.6M 0
Ziopharm Oncology ZIOP:US USD 216K 0